Craft

Radius Health

Stock Price

$17.1

2024-10-29

Market Capitalization

$480.6 M

2024-10-29

Revenue

$230 M

FY, 2021

Radius Health Summary

Company Summary

Overview
Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The Сompany's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life. Their long-term focus is on additional areas in women's health that include symptoms of menopause, reproductive disorders, and frailty associated with aging.
Type
Public
Status
Active
Founded
2003
HQ
Boston, MA, US | view all locations
Website
http://www.radiuspharm.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Averi Price

    Averi Price, General Counsel and Chief Compliance Officer

  • Willard H. Dere, Director

    • Catherine Friedman

      Catherine Friedman, Director

      • Jean-Pierre Garnier, Director

        LocationsView all

        2 locations detected

        • Boston, MA HQ

          United States

          22 Boston Wharf Rd 7th Floor

        • Wayne, PA

          United States

          CrossPoint at Valley Forge, 550 Swedesford Rd #370

        Radius Health Financials

        Summary Financials

        Revenue (Q2, 2022)
        $58.3M
        Net income (Q2, 2022)
        ($12.7M)
        Cash (Q2, 2022)
        $72.5M
        EBIT (Q2, 2022)
        ($7.9M)
        Enterprise value
        $557.6M

        Footer menu